The balloon aortic valvuloplasty market size is projected to reach US$ 190.27 million by 2031 from US$ 125.08 million in 2023. The market is expected to register a CAGR of 5.4% during 2023–2031. Emerging research and development strategies that help improve transcatheter aortic valve implantation (TAVI) are likely to remain key trends in the market.
Balloon Aortic Valvuloplasty Market Analysis
The factors driving the growth of the balloon valvuloplasty device market include the rapidly aging population and the increasing prevalence rate of aortic valve stenosis. Aortic stenosis has become the most common valvular disease that requires surgical treatment. Balloon aortic valvuloplasty (BAV) can be helpful in a wide range of patients with aortic stenosis, as well as being a bridging therapy to valve replacement, besides its role in TAVI procedures. Rising availability of medical reimbursements for balloon valvuloplasty devices, growing adoption of minimally invasive surgeries, and better healthcare infrastructure are additional factors contributing to the market growth. Minimally invasive approaches usually involve smaller incisions with the use of specialized instruments and technologies to access the heart, which can lead to shorter hospital stays and less scarring. Additionally, healthcare organizations are investing in training their medical teams and obtaining the necessary equipment to meet the growing demand for minimally invasive BAV and TAVI surgeries, thereby providing patients with enhanced treatment options and better overall healthcare experiences. Thus, the balloon aortic valvuloplasty market witnesses notable growth.
Balloon Aortic Valvuloplasty Market Overview
More than half of patients suffering from severe heart valve disease die within two years of acquiring the symptoms. Survey results published by Global Heart Hub in Heart Valve Voice Canada 2020 state that only 3% of Canadians aged 60 and above are aware of aortic stenosis. Increased awareness and early detection of heart valve disease are therefore essential for patients, along with those dependent on them and the local community. The Canadian Cardiovascular Society formed a Heart Valve Disease Strategy Working Group to address gaps in heart valve disease care in Canada. In January 2021, Medtronic received an expanded indication from Health Canada for the Evolut TAVI system. Medtronic's TAVI platform is the only system licensed for both bicuspid aortic valves (intermediate or higher risk patients). Evolut is indicated in the country for severe aortic stenosis patients across all risk categories. In September 2021, Abbott received the US Food and Drug Administration (FDA) approval for Portico with FlexNav transcatheter aortic valve replacement (TAVR) system to treat people with symptomatic, severe aortic stenosis who are at high risk for open-heart surgery.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Balloon Aortic Valvuloplasty Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Balloon Aortic Valvuloplasty Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Balloon Aortic Valvuloplasty Market Drivers and Opportunities
Growing Demand for Minimally Invasive Procedures Favors Market Growth
The soaring demand for minimally invasive techniques in valve replacement surgeries reflects a significant shift in medical practices and patient preferences. In a minimally invasive aortic valvuloplasty, the heart's aortic valve is repaired and, if needed, replaced through TAVI procedures. Minimally invasive techniques are driven by the desire to reduce the invasiveness of procedures, minimize the associated risks, and promote faster recovery times.
All branches of medicine, including cardiology, are witnessing an increase in the demand for less invasive procedures because of several benefits over traditional open-heart surgery. Compared to open-heart surgery, patients who undergo minimally invasive procedures usually have a shorter recovery time. In addition, minimally invasive techniques have a lower risk of complications and result in fewer scars compared to open cardiac surgery. Surgeons have adopted these techniques due to advancements in medical devices, and improved surgical skills can further facilitate widespread adoption. As BAV is a minimally invasive technique that can be used to treat a variety of heart problems, including aortic valve stenosis, the market for BAV devices is driven by the increased demand for minimally invasive procedures.
Advancements in Aortic Valve Replacement Technologies
Patients with heart conditions experience improved symptoms within a shorter period when treated with transcatheter procedures compared with surgical interventions. Minimally invasive surgical techniques, such as TAVI, have modernized the treatment of aortic stenosis due to advancements. Additionally, improvements in design have led to the development of stronger and biocompatible aortic valve replacements, which have enhanced patient outcomes and lowered the risk of complications. A few technological advancements by the companies in balloon aortic valvuloplasty and aortic valve replacement devices are mentioned below:
- In January 2023, Abbott received FDA approval for the Navitor TAVI system to treat patients with severe aortic stenosis and those who are ineligible for open-heart surgery. Navitor has been newly introduced in the company's extensive transcatheter structural heart portfolio; it offers physicians and patients less invasive treatment alternatives for a range of serious heart conditions.
- In September 2020, Boston Scientific introduced the ACURATE neo2 aortic valve system in Europe. The next-generation TAVI technology—a new platform designed with multiple features to improve the clinical performance of the original ACURATE neo platform—had an extended indication for patients with aortic stenosis compared to the aortic valve system of the previous generation.
Therefore, technological advancements are offering lucrative opportunities for the balloon aortic valvuloplasty market growth.
Balloon Aortic Valvuloplasty Market Report Segmentation Analysis
The key segment that contributed to the derivation of the balloon aortic valvuloplasty market analysis is product type.
Based on product type, the balloon aortic valvuloplasty market is bifurcated into non-compliant balloons and semi-compliant balloons. The non-compliant balloons segment held a larger market share in 2023 and is expected to register a higher CAGR in the market during 2023–2031.
Balloon Aortic Valvuloplasty Market Share Analysis by Geography
The geographic scope of the balloon aortic valvuloplasty market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America held a significant share of the market. The growth of the market in this region is attributed to the rising prevalence of heart valve diseases, increasing initiatives by various organizations to raise awareness about heart valve diseases among the population, and advancements made in treatment devices. According to the Organization for Economic Co-operation and Development, the burden of cardiovascular diseases is increasing rapidly in Mexico. The risk factors associated with heart diseases among the adult and geriatric population are being addressed in Mexico via awareness programs. In response to these awareness programs, transcatheter aortic valve replacement surgeries have gained traction and are commonly preferred as an alternative to open-heart valve surgery. Cardiologists in Mexico City perform TAVI using the best technology and techniques. CMQ Hospitals is a leader in the TAVI procedure in Puerto Vallarta and Riviera Nayarit. The hospitals have a multidisciplinary team of professionals in interventional cardiology, guaranteeing comprehensive and personalized care for each patient.
The most common cause of aortic stenosis in Canada is degenerative valve disease due to aging, followed by congenital bicuspid aortic valve disease and rheumatic heart disease. As per the “Heart Valve Disease in Canada,” published by the Institute of Health Economics in March 2022, aortic stenosis and mitral regurgitation are the two most common heart valve diseases. About 2.5% of the country’s population is reported to have heart valve disease, which increases significantly after the age of 65, reaching 13% in people aged 75 and above. It is estimated that 1.5 million people aged above 65 will suffer from heart valve disease by 2040 in Canada.
In Canada, a significant number of market players offer TAVI products. Edwards Lifesciences, Boston Scientific Corporation, Medtronic Inc., JenaValve Technology, and Transcatheter Technologies GmbH are a few manufacturers operating in the market. These manufacturers have received regulatory approvals from the Canadian government. Edwards SAPIEN and Medtronic CoreValve systems have been granted licenses in Canada.
Balloon Aortic Valvuloplasty Market Report Scope
Balloon Aortic Valvuloplasty Market News and Recent Developments
The balloon aortic valvuloplasty market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the balloon aortic valvuloplasty market are listed below:
- Abbott launched its latest-generation TAVI system, Navitor, in India, making the minimally invasive device available for people with severe aortic stenosis who are at high or extreme surgical risk in the country. Navitor features a unique fabric cuff (NaviSeal) that works with the cardiac cycle to minimize or eliminate a backflow of blood across the valve frame, known as paravalvular leak. (Source: Abbott, Press Release, December 2022)
- Keystone Heart, Ltd., entered into an exclusive distribution agreement with InterValve Medical Inc. to sell and market their portfolio of balloon aortic valvuloplasty products in the US. Under the agreement, Keystone Heart Ltd. began selling the V8 and TAV8 aortic valvuloplasty balloon catheters (InterValve Medical) in the US market. (Source: Keystone Heart, Ltd; Press Release, March 2021)
Balloon Aortic Valvuloplasty Market Report Coverage and Deliverables
The “Balloon Aortic Valvuloplasty Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Balloon aortic valvuloplasty market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Balloon aortic valvuloplasty market trends as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Balloon aortic valvuloplasty market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the balloon aortic valvuloplasty market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The estimated value of the balloon aortic valvuloplasty market can reach US$ 190.27 million by 2031.
North America region dominated the balloon aortic valvuloplasty market in 2023.
B Braun SE, TT Medical, Inc., Balton, Becton Dickinson and Co, Edwards Lifesciences Corp, Balt, Venus MedTech HangZhou Inc., NuMED, simeks, and OSYPKA are among the key market players in the balloon aortic valvuloplasty market.
The global balloon aortic valvuloplasty market is estimated to register a CAGR of 5.4% during the forecast period 2023–2031.
The rising prevalence of aortic valve stenosis and increasing demand for minimally invasive procedures are the most influential factors responsible for market growth.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Balloon Aortic Valvuloplasty Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Regional Pricing Analysis, By Product Type, 2023
5. Balloon Aortic Valvuloplasty Market – Key Market Dynamics
5.1 Balloon Aortic Valvuloplasty Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Aortic Valve Stenosis
5.2.2 Increasing Demand for Minimally Invasive Procedures
5.3 Market Restraints
5.3.1 High Cost of Procedures
5.4 Market Opportunities
5.4.1 Advancements in Aortic Valve Replacement Technologies
5.5 Future Trends
5.5.1 Improvements in TAVI Combined with Research and Development
5.6 Impact of Drivers and Restraints:
6. Balloon Aortic Valvuloplasty Market – Global Market Analysis
6.1 Balloon Aortic Valvuloplasty Market Revenue (US$ Thousand), 2021–2031
6.2 Market Positioning Analysis, 2023
7. Balloon Aortic Valvuloplasty Market Analysis – by Product Type
7.1 Overview
7.2 Global: Balloon Aortic Valvuloplasty Market – – Revenue and Forecast Analysis – by Product Type
7.3 Global: Balloon Aortic Valvuloplasty Market – – Volume and Forecast Analysis – by Product Type
7.4 Non Compliant Balloons
7.4.1 Overview
7.4.2 Non Compliant Balloons: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
7.5 Semi Compliant Balloons
7.5.1 Overview
7.5.2 Semi Compliant Balloons: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8. Balloon Aortic Valvuloplasty Market – Geographical Analysis
8.1 Overview
8.2 North America
8.2.1 North America Balloon Aortic Valvuloplasty Market Overview
8.2.2 North America: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.2.3 North America: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.2.3.1 North America: Balloon Aortic Valvuloplasty Market – Revenue and Forecast Analysis – by Product Type
8.2.3.2 North America: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis – by Product Type
8.2.4 North America: Balloon Aortic Valvuloplasty Market – Revenue and Forecast Analysis – by Country
8.2.4.1 Canada: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.2.4.1.1 Canada: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.2.4.1.2 Canada: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.2.4.2 Mexico: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.2.4.2.1 Mexico: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.2.4.2.2 Mexico: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.3 Europe
8.3.1 Europe Balloon Aortic Valvuloplasty Market Overview
8.3.2 Europe: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.3.3 Europe: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.3.3.1 Europe: Balloon Aortic Valvuloplasty Market – Revenue and Forecast Analysis – by Product Type
8.3.3.2 Europe: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.3.4 Europe: Balloon Aortic Valvuloplasty Market – Revenue and Forecast Analysis – by Country
8.3.4.1 Germany: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.3.4.1.1 Germany: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.3.4.1.2 Germany: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.3.4.2 United Kingdom: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.3.4.2.1 United Kingdom: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.3.4.2.2 United Kingdom: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.3.4.3 France: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.3.4.3.1 France: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.3.4.3.2 France: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.3.4.4 Italy: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.3.4.4.1 Italy: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.3.4.4.2 Italy: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.3.4.5 Spain: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.3.4.5.1 Spain: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.3.4.5.2 Spain: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.3.4.6 Rest of Europe: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.3.4.6.1 Rest of Europe: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.3.4.6.2 Rest of Europe: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.4 Asia Pacific
8.4.1 Asia Pacific Balloon Aortic Valvuloplasty Market Overview
8.4.2 Asia Pacific: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.4.3 Asia Pacific: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.4.3.1 Asia Pacific: Balloon Aortic Valvuloplasty Market – Revenue and Forecast Analysis – by Product Type
8.4.3.2 Asia Pacific: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.4.4 Asia Pacific: Balloon Aortic Valvuloplasty Market – Revenue and Forecast Analysis – by Country
8.4.4.1 China: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.4.4.1.1 China: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.4.4.1.2 China: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.4.4.2 Japan: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.4.4.2.1 Japan: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.4.4.2.2 Japan: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.4.4.3 India: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.4.4.3.1 India: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.4.4.3.2 India: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.4.4.4 South Korea: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.4.4.4.1 South Korea: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.4.4.4.2 South Korea: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.4.4.5 Australia: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.4.4.5.1 Australia: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.4.4.5.2 Australia: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.4.4.6 Rest of APAC: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.4.4.6.1 Rest of APAC: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.4.4.6.2 Rest of APAC: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.5 Middle East and Africa
8.5.1 Middle East and Africa Balloon Aortic Valvuloplasty Market Overview
8.5.2 Middle East and Africa: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.5.3 Middle East and Africa: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.5.3.1 Middle East and Africa: Balloon Aortic Valvuloplasty Market – Revenue and Forecast Analysis – by Product Type
8.5.3.2 Middle East and Africa: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.5.4 Middle East and Africa: Balloon Aortic Valvuloplasty Market – Revenue and Forecast Analysis – by Country
8.5.4.1 Saudi Arabia: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.5.4.1.1 Saudi Arabia: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.5.4.1.2 Saudi Arabia: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.5.4.2 South Africa: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.5.4.2.1 South Africa: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.5.4.2.2 South Africa: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.5.4.3 United Arab Emirates: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.5.4.3.1 United Arab Emirates: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.5.4.3.2 United Arab Emirates: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.5.4.4 Rest of Middle East and Africa: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.5.4.4.1 Rest of Middle East and Africa: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.5.4.4.2 Rest of Middle East and Africa: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.6 South and Central America
8.6.1 South and Central America Balloon Aortic Valvuloplasty Market Overview
8.6.2 South and Central America: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.6.3 South and Central America: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.6.3.1 South and Central America: Balloon Aortic Valvuloplasty Market – Revenue and Forecast Analysis – by Product Type
8.6.3.2 South and Central America: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.6.4 South and Central America: Balloon Aortic Valvuloplasty Market – Revenue and Forecast Analysis – by Country
8.6.4.1 Brazil: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.6.4.1.1 Brazil: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.6.4.1.2 Brazil: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.6.4.2 Argentina: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.6.4.2.1 Argentina: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.6.4.2.2 Argentina: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.6.4.3 Rest of South and Central America: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.6.4.3.1 Rest of South and Central America: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.6.4.3.2 Rest of South and Central America: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
9. Company Profiles
9.1 B Braun SE
9.1.1 Key Facts
9.1.2 Business Description
9.1.3 Products and Services
9.1.4 Financial Overview
9.1.5 SWOT Analysis
9.1.6 Key Developments
9.2 TT Medical, Inc.
9.2.1 Key Facts
9.2.2 Business Description
9.2.3 Products and Services
9.2.4 Financial Overview
9.2.5 SWOT Analysis
9.2.6 Key Developments
9.3 Balton
9.3.1 Key Facts
9.3.2 Business Description
9.3.3 Products and Services
9.3.4 Financial Overview
9.3.5 SWOT Analysis
9.3.6 Key Developments
9.4 Becton Dickinson and Co
9.4.1 Key Facts
9.4.2 Business Description
9.4.3 Products and Services
9.4.4 Financial Overview
9.4.5 SWOT Analysis
9.4.6 Key Developments
9.5 Edwards Lifesciences Corp
9.5.1 Key Facts
9.5.2 Business Description
9.5.3 Products and Services
9.5.4 Financial Overview
9.5.5 SWOT Analysis
9.5.6 Key Developments
9.6 Balt
9.6.1 Key Facts
9.6.2 Business Description
9.6.3 Products and Services
9.6.4 Financial Overview
9.6.5 SWOT Analysis
9.6.6 Key Developments
9.7 Venus MedTech HangZhou Inc
9.7.1 Key Facts
9.7.2 Business Description
9.7.3 Products and Services
9.7.4 Financial Overview
9.7.5 SWOT Analysis
9.7.6 Key Developments
9.8 NuMED
9.8.1 Key Facts
9.8.2 Business Description
9.8.3 Products and Services
9.8.4 Financial Overview
9.8.5 SWOT Analysis
9.8.6 Key Developments
9.9 Simeks
9.9.1 Key Facts
9.9.2 Business Description
9.9.3 Products and Services
9.9.4 Financial Overview
9.9.5 SWOT Analysis
9.9.6 Key Developments
9.10 OSYPKA
9.10.1 Key Facts
9.10.2 Business Description
9.10.3 Products and Services
9.10.4 Financial Overview
9.10.5 SWOT Analysis
9.10.6 Key Developments
10. Appendix
10.1 About The Insight Partners
List of Tables
Table 1. Balloon Aortic Valvuloplasty Market Segmentation
Table 2. Regional Pricing Analysis, By Product Type, 2023
Table 3. Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand) – by Product Type
Table 4. Global: Balloon Aortic Valvuloplasty Market – Volume (Units) and Forecast to 2031(Units) – by Product Type
Table 5. North America: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 6. North America: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031(Units) – by Product Type
Table 7. Canada: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 8. Canada: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 9. Mexico: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 10. Mexico: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 11. Europe: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 12. Europe: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 13. Germany: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 14. Germany: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 15. United Kingdom: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 16. United Kingdom: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 17. France: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 18. France: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 19. Italy: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 20. Italy: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 21. Spain: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 22. Spain: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 23. Rest of Europe: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 24. Rest of Europe: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 25. Asia Pacific: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 26. Asia Pacific: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 27. China: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 28. China: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 29. Japan: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 30. Japan: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 31. India: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 32. India: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 33. South Korea: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 34. South Korea: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 35. Australia:
Table 36. Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 37. Australia: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 38. Rest of APAC: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 39. Rest of APAC: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 40. Middle East and Africa: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 41. Middle East and Africa: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 42. Saudi Arabia: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 43. Saudi Arabia: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 44. South Africa: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 45. South Africa: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 46. United Arab Emirates: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 47. United Arab Emirates: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 48. Rest of Middle East and Africa: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 49. Rest of Middle East and Africa: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 50. South and Central America: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 51. South and Central America: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 52. Brazil: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 53. Brazil: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 54. Argentina: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 55. Argentina: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 56. Rest of South and Central America: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 57. Rest of South and Central America: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 58. Appendix: Balloon Aortic Valvuloplasty Market
List of Figures
Figure 1. Balloon Aortic Valvuloplasty Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Balloon Aortic Valvuloplasty Market Revenue (US$ Thousand), 2021–2031
Figure 5. Ballon Aortic Valvuloplasty Market, By Geography Forecast Analysis, 2023 & 2031
Figure 6. Market Positioning Analysis, 2023
Figure 7. Balloon Aortic Valvuloplasty Market Share (%) – by Product Type (2023 and 2031)
Figure 8. Non Compliant Balloons: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 9. Semi Compliant Balloons: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 10. Balloon Aortic Valvuloplasty Market Breakdown by Region, 2023 and 2031 (%)
Figure 11. North America: Ballon Aortic Valvuloplasty Market by Key Countries – Revenue 2023 (US$ Thousand)
Figure 12. North America: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 13. North America: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type (2023 and 2031)
Figure 14. North America: Balloon Aortic Valvuloplasty Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 15. Canada: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 16. Mexico: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 17. Europe: Ballon Aortic Valvuloplasty Market by Key Countries – Revenue 2023 (US$ Thousand)
Figure 18. Europe: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 19. Europe: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type (2023 and 2031)
Figure 20. Europe: Balloon Aortic Valvuloplasty Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 21. Germany: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 22. United Kingdom: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 23. France: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 24. Italy: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 25. Spain: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 26. Rest of Europe: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 27. Asia Pacific: Ballon Aortic Valvuloplasty Market by Key Countries – Revenue 2023 (US$ Thousand)
Figure 28. Asia Pacific: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 29. Asia Pacific: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type (2023 and 2031)
Figure 30. Asia Pacific: Balloon Aortic Valvuloplasty Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 31. China: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 32. Japan: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 33. India: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 34. South Korea: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 35. Australia: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 36. Rest of APAC: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 37. Middle East and Africa: Ballon Aortic Valvuloplasty Market by Key Countries – Revenue 2023 (US$ Thousand)
Figure 38. Middle East and Africa: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 39. Middle East and Africa: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type (2023 and 2031)
Figure 40. Middle East and Africa: Balloon Aortic Valvuloplasty Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 41. Saudi Arabia: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 42. South Africa: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 43. United Arab Emirates: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 44. Rest of Middle East and Africa: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 45. South and Central America: Ballon Aortic Valvuloplasty Market by Key Countries – Revenue 2023 (US$ Thousand)
Figure 46. South and Central America: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 47. South and Central America: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type (2023 and 2031)
Figure 48. South and Central America: Balloon Aortic Valvuloplasty Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 49. Brazil: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 50. Argentina: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 51. Rest of South and Central America: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
The List of Companies - Balloon Aortic Valvuloplasty Market
- B Braun SE
- TT Medical, Inc.
- Balton
- Becton Dickinson and Co
- Edwards Lifesciences Corp
- Balt
- Venus MedTech HangZhou Inc
- NuMED
- simeks
- OSYPKA
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Balloon Aortic Valvuloplasty Market
Jun 2024
Laser-Assisted ENT Surgeries Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Laser Type (C02 Laser, Nd:YAG Laser, Diode Laser, Blue Laser, KTP Laser, Argon Laser, and Other Laser Types), Surgery Type [Laser Laryngeal Surgery, Laser Endoscopic Sinus Surgery (LESS), Laser-Assisted Uvulopalatoplasty (LAUP), Laser-Assisted Stapedotomy, Laser-Assisted Tonsillectomy and Adenoidectomy, Laser Turbinates Reduction, Transoral Laser Microsurgery (TLM), Nasal Surgery, and Other Surgery Types], End User (Hospitals and Specialty Clinics, Physician Offices, and Other End Users), and Geography (North America, Europe, Asia Pacific, South and Central America, and Middle East and Africa)
Jun 2024
Mobile Cleanroom Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Softwall and Hardwall), End User (Microelectronics Industry, Pharmaceuticals and Biotechnology Industry, Medical Device Manufacturers, and Others), and Geography
Jun 2024
Ovo-Sexing Technology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technique (Non-Invasive Imaging, Genetic Editing, Volatile Analysis, Sex Reversal, and Liquid-Based Analysis), End User (Hatcheries and Poultry Farms), and Geography (US, Germany, France, Italy, Spain, Rest of Europe, Israel, and ROW)
Jun 2024
Dental Laser Treatment Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Hard Tissue, Soft Tissue, and Others), End User (Hospitals, Dental Clinics, Dental-Owned Practices, and Others), Clinical Indication [Conservative Dentistry, Root Canal (Endodontic Treatment), Oral Surgery, Implantology, Peri-Implantitis, Periodontics, and Others], and Geography
Jun 2024
Microbiology CRO Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Clinical, Medical Device, and Others), Service Type (Assay Development, Custom Viral Stock Production, Microbial Testing, and Others), Microorganisms (Bacteria, Fungi, Viruses, and Parasites), End User (Biotech and Pharmaceutical Companies, Medical Device Companies, and Others), and Geography
Jun 2024
Antimicrobial Surgical Suture Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Triclosan Antimicrobial Suture and Chlorhexidine Antimicrobial Suture), Raw Materials (Polyglactin 910 Antimicrobial Suture, Poliglecaprone 25, and Polyglycolic Acid), Application (Cardiovascular Surgery, General Surgery, Ophthalmic Surgery, Gynecological Surgery, Orthopedic Surgery, Plastic Surgery, Veterinary Surgery, Dental Surgery, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2024
Fall Management Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sensor Pads, Floor Mat, Hip Protectors, Alert Systems, Communication Devices, and Other Products), Application (Fall Detection Systems, Fall Prevention Equipment, and Post-Fall Monitoring and Response Systems), Age Group [Elderly Population (65 and Above) and Adults (18–64 years)], End User (Hospitals and Clinics, Nursing Homes, Home Care Settings, and Other End Users), and Geography
Jun 2024
Organoids Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Get Free Sample For